Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns. - Wikidata - awgldk - TriplyDB

Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns.

Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns.

http://www.wikidata.org/entity/Q34381513

about

Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data.Lectin-carbohydrate interactions on nanoporous gold monoliths.Sweetening the pot: adding glycosylation to the biomarker discovery equation Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer.Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.Glycoprotein analysis using protein microarrays and mass spectrometry.Integrated analyses of proteins and their glycans in a magnetic bead-based multiplex assay format.Glycosylation potential of human prostate cancer cell lines.Proteomics in prostate cancer biomarker discovery.The glycolyzer: automated glycan annotation software for high performance mass spectrometry and its application to ovarian cancer glycan biomarker discovery.Simultaneous analysis of glycosylated and sialylated prostate-specific antigen revealing differential distribution of glycosylated prostate-specific antigen isoforms in prostate cancer tissues Integration of the transcriptome and glycome for identification of glycan cell signatures.The sweet and sour of serological glycoprotein tumor biomarker quantification.Serum fucosylated prostate-specific antigen (PSA) improves the differentiation of aggressive from non-aggressive prostate cancers.Aberrant glycosylation associated with enzymes as cancer biomarkers.The analysis of sialylation, N-glycan branching, and expression of O-glycans in seminal plasma of infertile men.A lectin affinity workflow targeting glycosite-specific, cancer-related carbohydrate structures in trypsin-digested human plasma.Identification of sialylated glycoproteins from metabolically oligosaccharide engineered pancreatic cells.The detection and discovery of glycan motifs in biological samples using lectins and antibodies: new methods and opportunities.Biomarker discovery by novel sensors based on nanoproteomics approaches.Lectin chromatography/mass spectrometry discovery workflow identifies putative biomarkers of aggressive breast cancers.A systematic framework to derive N-glycan biosynthesis process and the automated construction of glycosylation networks.Altered expression of sialylated glycoproteins in breast cancer using hydrazide chemistry and mass spectrometry.Sensitive detection and glycoprofiling of a prostate specific antigen using impedimetric assays.Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes.N-Glycan profile analysis of transferrin using a microfluidic compact disc and MALDI-MS Characterization of disease-associated N-linked glycoproteins State of the art in tumor antigen and biomarker discovery.Analysis of serum protein glycosylation by a differential lectin immunosorbant assay (dLISA).Glycoproteomics using fluid-based specimens in the discovery of lung cancer protein biomarkers: promise and challenge.Application of cancer-associated glycoforms and glycan-binding probes to an in vitro diagnostic multivariate index assay for precise diagnoses of cancer Characterizing Protein Glycosylation through On-Chip Glycan Modification and Probing High-Throughput Analysis of Plasma Hybrid Markers for Early Detection of Cancers.Highly glycosylated tumour antigens: interactions with the immune system.Recent advances in developing synthetic carbohydrate-based vaccines for cancer immunotherapies.Using lectins to harvest the plasma/serum glycoproteome.Seminal plasma glycoproteins in male infertility and prostate diseases: is there a chance for glyco-biomarkers?Aberrant PSA glycosylation--a sweet predictor of prostate cancer.Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers.Glycoproteomics-based identification of cancer biomarkers.

P2860

Q33504781-39397821-5378-4C12-950B-164EEB0D2BCA Q33686539-5131FEE0-6AB4-4E5B-A712-205A95941591 Q33768460-81963800-C332-473B-8593-C7BD2AF3354F Q33850105-E9C1357F-4492-47EB-9CA5-DB35A3881336 Q33891197-0A734E09-47C4-423E-834C-17135600A9AF Q33927735-04FDBC27-4DB9-4650-83A2-3D8ECCF055C5 Q33977544-BF1AB78C-79E9-49E4-8215-C94CAA0800B4 Q34046293-B0C61583-BEE2-4F73-8799-A925493F03B6 Q34096086-88829D76-151B-4A56-AF75-3174811C85B2 Q34383959-1A9B4997-36D0-491F-BE64-3E0409B9F9AE Q34541208-EC3A996F-0181-44B3-8EFD-D8CC7670E98A Q34550700-584350C6-E2A1-4696-82C9-67847886AFEC Q34580285-2B1CB229-06EF-4144-988D-137AE51834F2 Q34785893-9D479539-A5F0-43ED-B8BA-DA496C22D2D9 Q35206309-974E669E-9B8E-40A8-B8E9-8BDDCE7DAC4E Q35372905-B3F9B22A-3FEF-4427-856C-BD0DBFF57301 Q35499086-FC8E5F0E-DB6A-4974-9832-AF06BB3799E3 Q35615401-95CE32D1-9ECA-41AA-B613-10DC321529C1 Q35794259-1B329A5B-732E-474C-BB5A-B032C81CC275 Q35831485-9512D623-ECCE-456D-876F-8FA72AC720D8 Q36058024-ABBBE6E5-4D90-40BA-920B-A298CC9CB432 Q36084452-D2E85588-D40B-4D92-8502-4DD5E2F50B4E Q36208974-864A9183-75A7-4E84-88CE-DC6875626C53 Q36945404-CEA5C7A8-2280-4FB3-B698-EB070F77EFC7 Q36970387-A6041FFB-2233-48AE-B70A-96CE92C82EAE Q37009594-744F261A-2F13-4E35-99BF-3E84C6C8E8CC Q37069869-B22FE76B-6B04-4F63-97A6-B17BF8351B2E Q37132800-E84BF0A4-6805-47E2-A307-E4119E3190CE Q37357377-55C393AE-0F0B-48AE-9C23-9D45FD92D7F5 Q37365408-8F5A7188-5087-48A9-972C-D3D7365D97D6 Q37565619-0FB5DBB3-C254-4CFD-8CE7-2ED3678DFF29 Q37623120-9297309C-E2BA-4F00-937C-DC14B003D26B Q37636426-EFA0874A-0654-44A5-BB0A-16AE5F951A89 Q37832274-62CA51CF-CB16-4295-96DF-808CAAAF73A6 Q37993590-4D6CCF88-A45E-48E5-B8BD-3D25BE696A34 Q38022218-B481BD6F-371A-4B22-812F-CDD72352E5B8 Q38051694-2D6A5E74-E2F0-4AFA-A1D9-23A1FF34F0F4 Q38074010-3A91F96E-24AD-4256-AD5A-D36AF1E94B02 Q38194576-40EDF389-03E4-479A-8777-F9565C6CF326 Q38738207-AE000A41-002C-4425-8DBE-7E4F1B91BD03

P2860

Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns.

http://www.wikidata.org/entity/Q34381513

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Glycoproteomics for prostate c ...... um PSA glycosylation patterns.

@ast

Glycoproteomics for prostate c ...... um PSA glycosylation patterns.

@en

Glycoproteomics for prostate c ...... um PSA glycosylation patterns.

@nl

type

label

Glycoproteomics for prostate c ...... um PSA glycosylation patterns.

@ast

Glycoproteomics for prostate c ...... um PSA glycosylation patterns.

@en

Glycoproteomics for prostate c ...... um PSA glycosylation patterns.

@nl

prefLabel

Glycoproteomics for prostate c ...... um PSA glycosylation patterns.

@ast

Glycoproteomics for prostate c ...... um PSA glycosylation patterns.

@en

Glycoproteomics for prostate c ...... um PSA glycosylation patterns.

@nl

P1433

Q34381513-1168DF36-AB60-495A-87C7-F17B0051D7AE

P1476

Q34381513-450F3B1B-DDF7-46EE-8BAB-8236D676CFDE

P2093

Q34381513-2707CD5B-E789-464C-B37E-43CC1ADC9B09

Q34381513-6AB99787-DB8E-43C0-AC36-B2309A3C1467

Q34381513-6C4BCF49-56FA-4393-AEB9-28C7C1AF8B0B

Q34381513-CCE15394-B113-4856-95A4-6A46CBEB1CF4

Q34381513-E8370E37-6A1E-43D3-AE0C-707BDD1A0D85

P2860

Q34381513-0AE6901A-9420-4F9B-B4B6-D8FFA0CFBE07

Q34381513-128206C0-64BC-456F-950A-4ACDE76F7846

Q34381513-19B6E352-A54E-4F63-9D6C-3C4BD8BC8A4E

Q34381513-2C50053D-62FC-4398-8862-141E39349FAC

Q34381513-3455D7FA-993B-4392-80A0-B92D43092465

Q34381513-3D5FDF20-0FE7-46A1-B2EE-D090FA548A27

Q34381513-50DA0CA9-6D43-4C00-A3AE-7C4B53B8CC34

Q34381513-67D4C6A3-E3A2-4AF9-8543-F512BF885E84

Q34381513-70F7D44C-0AB7-49E3-8E7E-12305B24FA8E

Q34381513-756F2F6A-EAA3-437F-B4BE-165B638194D5

P304

Q34381513-971929C5-5601-4F35-94DA-072E57C3E967

P31

Q34381513-F6F492CD-6240-4EB3-9AFF-B676C8AFA9A2

P356

Q34381513-E8306DEF-93C5-4343-A27C-CDB858E60DE5

P433

Q34381513-3A3991E5-F4F8-450D-835F-0C02D04C7181

P478

Q34381513-86CACA7C-7EB7-4847-BBFA-76B260E788EA

P577

Q34381513-38955DB9-274E-4D5A-922C-3BFE342169F3

P5875

Q34381513-A9A06C0D-F6B8-4890-BF51-1C84B13E7A4B

P698

Q34381513-10BDEA76-BBDD-4F3C-ADAD-4EFFE03DBA2B

P921

Q34381513-31CE4F49-E1AE-41B3-8587-2EF6F831C817

P932

Q34381513-2382EB7C-6EC4-4A38-A912-C0E6917D76D7

P356

P1433

Journal of Proteome Research

P1476

Glycoproteomics for prostate c ...... um PSA glycosylation patterns.

@en

P2093

Daniel W Chan

http://www.w3.org/2001/XMLSchema#string

Danni L Meany

http://www.w3.org/2001/XMLSchema#string

Hui Zhang

http://www.w3.org/2001/XMLSchema#string

Lori J Sokoll

http://www.w3.org/2001/XMLSchema#string

Zhen Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Increased Levels of Galactose-Deficient Anti-Gal Immunoglobulin G in the Sera of Hepatitis C Virus-Infected Individuals with Fibrosis and Cirrhosis

Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry

Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins.

Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach.

Protein glycosylation and diseases: blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring.

Free prostate-specific antigen in serum is becoming more complex.

Prostate-specific antigen: current status.

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer.

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

P304

613-619

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/PR8007539

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23499600

http://www.w3.org/2001/XMLSchema#string

P698

19035787

http://www.w3.org/2001/XMLSchema#string

P921

P932

2997339

http://www.w3.org/2001/XMLSchema#string